YFYoshimitsu Fukushima

Yoshimitsu Fukushima

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yoshimitsu Fukushima has a total of 274 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Short-time deep-inspiratory breath-hold pulmonary perfusion SPECT/CT in interstitial pneumonia: a vascular dimension that stratifies risk independently of the GAP score

    by Yoshimitsu Fukushima, Kenji Yodogawa, Yujiro Nakaoka, Yoshimitsu Honda, Satoshi Harashina, Kyouji Asano, Hiromitsu Hayashi, Shinichiro Kumita

    Purpose: Risk in interstitial pneumonia (IP) is assessed routinely by the Gender–Age–Physiology (GAP) score from pulmonary function and the tricuspid regurgitation pressure gradient (TRPG) on echocardiography. This study evaluated whether the percent perfusion defect (%PPD) on short-time deep-inspiratory breath-hold (STDIBH) pulmonary perfusion SPECT/CT carries prognostic information that neither captures. Materials and methods: Ninety-one consecutive patients with IP who underwent STDIBH perfusion SPECT/CT between 2012 and 2023 were analyzed retrospectively. The primary endpoint was a composite major adverse event (MAE) of all-cause death, acute exacerbation of IP, respiratory-failure hospitalization, and initiation of home oxygen therapy. Association was assessed by Cox regression and discrimination by censoring-weighted time-dependent receiver operating characteristic analysis. Results: MAE occurred in 66 of 91 patients (72.5%) over a median follow-up of 45.9 months. %PPD was associated with MAE after adjustment for the GAP score and antifibrotic therapy (adjusted hazard ratio 1.2304 per 10 percentage points, 95% CI 1.0568–1.4325; P = 0.008), and, in exploratory analyses, for TRPG and the GAP score together (1.2058, 1.0314–1.4096; P = 0.019). It showed no significant correlation with TRPG (Spearman r = 0.164; P = 0.140). Time-dependent discrimination did not differ significantly between %PPD and the GAP score at 6, 12, and 24 months, and adding %PPD to the GAP score changed the Harrell C-index from 0.692 to 0.719 (difference 0.027, 95% CI − 0.009 to 0.107). %PPD was obtained in all 91 patients and the GAP score in 68 (74.7%). Conclusion: In IP, %PPD measures a dimension of risk that the GAP score does not capture, and exploratory analyses suggest that echocardiography does not capture it either. %PPD is obtainable when the GAP score is not. Its discrimination did not differ significantly from that of the GAP score, and adding it to the GAP score did not significantly improve discrimination.

  • Open Access

    Short-time deep-inspiratory breath-hold perfusion SPECT/CT in pulmonary emphysema: perfusion defect extent, not CT-quantified emphysema extent, tracks major adverse events

    by Yoshimitsu Fukushima, Teruhiko Hamana, Kenji Yodogawa, Takahiro Ando, Yujiro Nakaoka, Yoshimitsu Honda, Satoshi Harashina, Kyouji Asano, Hiromitsu Hayashi, Shinichiro Kumita

    Objective Computed tomography (CT) quantifies emphysema extent but not the accompanying perfusion loss. This study evaluated whether perfusion defect extent, the percent perfusion defect (%PPD) on short-time deep-inspiratory breath-hold (STDIBH) perfusion single-photon emission computed tomography/CT (SPECT/CT), is associated with major adverse events (MAE) in emphysema, and whether CT-quantified emphysema extent carries comparable information. Methods Of 91 patients with emphysema who underwent STDIBH perfusion SPECT/CT, 74 were analyzed retrospectively. Perfusion defect volume as a percentage of CT lung volume defined %PPD, and emphysema extent was the percentage of low-attenuation area (%LAA) on the same CT. MAE comprised all-cause death, hospitalization for respiratory failure or acute exacerbation of chronic obstructive pulmonary disease, and new home oxygen therapy. The primary analysis was Cox regression adjusted for B-type natriuretic peptide and for combined pulmonary fibrosis and emphysema (CPFE), supplemented by clinical adjustment, penalized estimation, restricted cubic splines, and exploratory time-dependent areas under the curve (AUCs). Results Over a median follow-up of 70.9 months, MAE occurred in 54 patients (73.0%). In the primary model, %PPD was associated with MAE (hazard ratio [HR] 1.1641 per 10%, 95% confidence interval [CI] 1.0437–1.2982, P = 0.006), and the estimate was similar after adjustment for age, sex, percent predicted forced expiratory volume in 1 s, and CPFE (HR 1.1651, 95% CI 1.0392–1.3063). Unadjusted %LAA was not significantly associated with MAE (HR 1.0080 per 1%, 95% CI 0.9884–1.0280, P = 0.425). The time-dependent AUC of %PPD exceeded that of %LAA at 36 months (difference 0.183, 95% CI 0.069–0.303) and 60 months (0.189, 0.044–0.338) but not clearly at 12 months (0.050, − 0.069 to 0.164). Risk rose up to a %PPD of about 55% and no further (nonlinearity P < 0.001). The planar Meyer perfusion score discriminated MAE similarly to %PPD (binary AUC 0.813 vs 0.776, P = 0.263). Conclusions In pulmonary emphysema, perfusion defect extent on STDIBH SPECT/CT, not CT-quantified emphysema extent, tracks major adverse events. Because STDIBH SPECT/CT measures the perfusion defect against the same CT that quantifies emphysema, one examination places the vascular and structural components of the disease on a common anatomical denominator.

  • Open Access

    Perfusion-Anatomy Concordance on Hybrid Cardiac SPECT/CT Identifies High-Risk Patients After Coronary Artery Bypass Grafting

    by Yoshimitsu Fukushima, Yosuke Ishii, Kenji Yodogawa, Yoshimitsu Honda, Hiromitsu Hayashi, Shinichiro Kumita

    Background: After coronary artery bypass grafting (CABG), graft and native-vessel anatomy complicate perfusion SPECT, and preoperative thresholds transfer poorly. We evaluated whether perfusion-anatomy concordance on hybrid SPECT/CT was associated with major adverse cardiac events (MACE) and compared it with perfusion severity and 123I-BMIPP mismatch.Methods: This retrospective study included 131 consecutive post-CABG patients who underwent stress/rest perfusion SPECT, 123I-BMIPP SPECT, and coronary CT angiography. Hybrid status was matched when a reversible defect corresponded to significant stenosis or occlusion in the supplying native artery or graft. Firth-penalized Cox regression was prespecified (5.4 events per parameter).Results: Over a median follow-up of 99.7 months (interquartile range 47.9–115.7), MACE occurred in 27 patients (20.6%). Event proportions were 38.8% versus 9.8% by matched status (log-rank P < 0.001), 30.4% versus 13.3% for a summed difference score ≥ 4 (P = 0.009), and 22.8% versus 18.9% for a summed mismatch score ≥ 7 (P = 0.269). After clinical adjustment, matched status remained associated with MACE (Firth-penalized hazard ratio 3.9970; 95% confidence interval 1.7666–9.7395; P < 0.001). This model showed the lowest unpenalized Akaike information criterion (226.32) and the highest ridge-stabilized optimism-corrected concordance index (0.704), with no proportional-hazards violation detected (P = 0.731). Perfusion severity was associated with MACE (unpenalized hazard ratio 2.9219; 1.2039–7.0916; P = 0.018) but showed evidence of nonproportional hazards (P = 0.036).Conclusions: Perfusion-anatomy concordance identifies a high-risk post-CABG subgroup. It provided the best model fit and, unlike perfusion severity, no evidence of nonproportional hazards. BMIPP mismatch was not associated with MACE.

  • Reduced ¹³N-Ammonia PET Myocardial Flow Reserve and Heart-Failure–Related Risk Independent of Relative Ischemia in Chronic Coronary Syndrome

    by Yoshimitsu Fukushima, Rika Kobayashi, Kenji Yodogawa, Shiori Shimizu, Shogo Imai, Hiromitsu Hayashi, Shinichiro Kumita

  • Open Access

    Platform-specific impact of CT attenuation correction on CZT myocardial perfusion SPECT: per-vessel detection of obstructive coronary artery disease

    by Yoshimitsu Honda, Yoshimitsu Fukushima, Kenji Yodogawa, Yujiro Nakaoka, Hiromitsu Hayashi, Shinichiro Kumita

  • Open Access

    Quantitative bone SPECT/CT-derived tumor burden as a prognostic biomarker in metastatic castration-resistant prostate cancer treated with Ra-223

    by Yoshimitsu Fukushima, Go Kimura, Jun Akatsuka, Yoshimitsu Honda, Yujiro Nakaoka, Hiromitsu Hayashi, Shinichiro Kumita

    Purpose: Metastatic castration-resistant prostate cancer (mCRPC) is bone-predominant, requiring objective imaging biomarkers to guide Ra-223 therapy. We evaluated overall metabolic bone volume (OMBV) and overall total bone uptake (OTBU) from bone SPECT/CT as prognostic markers in mCRPC patients treated with Ra-223. Methods: Thirty mCRPC patients underwent pre-treatment planar and SPECT/CT bone scintigraphy, with OMBV and OTBU derived using GI-BONE software. Overall survival (OS) was the primary endpoint; progression-free survival (PFS) and time to symptomatic skeletal event (TTSE) were secondary. Receiver operating characteristic analysis (Youden index) defined cut-offs for OS and TTSE independently. Treatment response was classified by composite changes in OMBV, OTBU, and bone scan index. OS, OMBV, and OTBU were analyzed by univariate Cox regression as continuous and dichotomized variables. Results: Baseline skeletal burden was substantial (median OMBV 1,191.21 cm 3 [IQR 93.80–1,948.01]; median OTBU 9,746.18 [1,280.01– 17,587.11]); 87% had extent of disease grade 3–4. Post-treatment imaging in 24 patients yielded 10 responders (42%) and 14 non-responders (58%), with responder mean OMBV and OTBU reductions of 57% and 68%. Dichotomized baseline OMBV (hazard ratio [HR] 6.0320, 95% confidence interval [CI] 1.6880–21.5546; p < 0.001) and OTBU (HR 9.4492, 95% CI 2.0968–42.5826; p < 0.001) were significant predictors of OS. OMBV and OTBU were not significantly associated with PFS or TTSE. Conclusions: OMBV and OTBU from bone SPECT/CT may provide useful prognostic information in mCRPC patients undergoing Ra-223 therapy, offering objective quantification of skeletal tumor burden using widely available technology. Further validation in larger cohorts is warranted.

  • Open Access

    Strict carbohydrate restriction enables volume-based FDG-PET/CT to outperform SUVmax for risk stratification in cardiac sarcoidosis

    by Yoshimitsu Fukushima, Takahiro Ando, Kenji Yodogawa, Tsutomu Igarashi, Hiromitsu Hayashi, Shinichiro Kumita

  • Open Access

    Prognostic value of volume-based FDG-PET/CT parameters quantified with strict carbohydrate restriction and delayed cardiac imaging in cardiac sarcoidosis

    by Yoshimitsu Fukushima, Takahiro Ando, Kenji Yodogawa, Tsutomu Igarashi, Hiromitsu Hayashi, Shinichiro Kumita

    Background: Cardiac sarcoidosis (CS) exhibits patchy, multifocal granulomatous inflammation inadequately represented by maximum standardized uptake value (SUVmax) on 18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT). Volume-based parameters, total cardiac metabolic volume (tCMV) and total cardiac metabolic activity (tCMA), integrate the extent and intensity of myocardial FDG uptake, yet their prognostic significance under optimized suppression conditions has not been evaluated for long-term outcomes. This study assessed whether tCMV and tCMA provide superior prediction of major adverse cardiac events (MACE) compared with SUVmax.Methods: In this prospective observational study, 48 consecutive patients with suspected CS underwent FDG-PET/CT after a 24-hour low-carbohydrate diet (glucose intake < 10 g), with delayed cardiac imaging at 120 minutes post-injection. SUVmax, tCMV, and tCMA were quantified using a fixed SUV threshold of 1.70. The primary endpoint was MACE (cardiac death, heart-failure hospitalization, or ventricular tachycardia), recorded over a median observation period of 7.3 years. ROC-derived cutoffs were used for Kaplan–Meier risk stratification, and Firth-penalized Cox regression identified independent predictors.Results: MACE occurred in 18 of 48 patients (37.5%). tCMA (AUC, 0.778) and tCMV (AUC, 0.776) showed superior discrimination over SUVmax (AUC, 0.618). On multivariate Cox regression, tCMA (hazard ratio [HR], 1.0010; 95% CI, 1.0005–1.0016; P = 0.0001) and New York Heart Association (NYHA) class (HR, 2.740; 95% CI, 1.624–4.626; P = 0.0002) were independently associated with MACE.Conclusions: Under stringent dietary suppression with delayed imaging, tCMA reflecting global granulomatous burden rather than focal intensity provided robust prognostic stratification for MACE in CS and may facilitate risk-adapted management.

  • Open Access

    Novel evaluation of pulmonary hypertension associated with chronic lung disease using perfusion SPECT/CT: A pilot study

    by Kenichiro Atsumi, Yoshimitsu Fukushima, Yosuke Tanaka, Shunichi Nishima, Toru Tanaka, Masahiro Seike, Yoshiaki Kubota, Hiroshi Kimura

    In pulmonary hypertension (PH) associated with chronic lung disease (CLD), identifying patients who would benefit from pulmonary vasodilators is a significant clinical challenge because the presence of PH is associated with poorer survival. This study evaluated the severity of pulmonary circulation impairment in patients with CLD‐PH using pulmonary perfusion single‐photon emission computed tomography/computed tomography (SPECT/CT). This single‐center, observational study enrolled patients with CLD‐PH who had a mean pulmonary arterial pressure (PAP) ≥ 25 mmHg, as confirmed by right heart catheterization. The primary outcome was to measure the percentage of pulmonary perfusion defect (%PPD), calculated by dividing the perfusion defect volume from perfusion SPECT images by the lung volume from CT scan images. The secondary outcome was to assess the correlation between %PPD and baseline characteristics. The median %PPD was 52.4% (interquartile range, 42.5%–72.3%) in 22 patients. In multivariate linear regression analysis, both forced vital capacity (β = 0.58, p = 0.008) and mean PAP (β = 0.68, p = 0.001) were significantly correlated with %PPD. In conclusion, significant correlation between mean PAP and %PPD in patients with CLD‐PH was observed. This noninvasive assessment of %PPD may be useful for evaluating the severity of pulmonary circulation impairment in CLD‐PH.


  • Open Access

    Clinical utility of67Gallium‐SPECT/CTfor determining osteotomy indication in patients with lower‐limb osteomyelitis

    by Sonoko Kirinoki‐Ichikawa, Gen Takagi, Yoshimitsu Fukushima, Shuhei Tara, Masaaki Miyamoto, Shinichiro Kumita

    Standard non‐invasive methods for diagnosing and selecting the best treatment for osteomyelitis in patients with multiple chronic conditions remain to be established. We aimed to evaluate the ability of quantitative67Ga‐citrate single‐photon emission computed tomography (67Ga‐SPECT/CT) to determine the indication for either non‐surgical treatment or osteotomy in patients with lower‐limb osteomyelitis (LLOM) associated with diabetes mellitus and lower‐extremity ischemia, based on monitoring of inflammatory activity in bone tissue. This single‐centre prospective study conducted from January 2012 to July 2017 included 90 consecutive patients with suspected LLOM. Regions of interest were drawn on SPECT images during quantification of Ga accumulation. Subsequently, the inflammation‐to‐background ratio (IBR) was calculated by dividing the maximal accumulated lesion number by the mean number for the distal femur bone marrow of the unaffected side. Osteotomy was performed in 28 of 90 patients (31%). The osteotomy rate was higher for patients with IBR >8.4 (71.4%) than for those with IBR ≤8.4 (5.5%) (p < 0.001, sensitivity: 0.89, specificity: 0.84). In the multivariate Cox regression analysis, IBR >8.4 was an independent risk factor for osteotomy (hazard ratio [HR]: 19.0, 95% confident interval [CI]: 5.6–63.9,p < 0.001). Transcutaneous oxygen tension (TcPO2) was identified as an independent risk factor for lower‐limb amputation (HR: 0.96, 95% CI: 0.92–0.99,p = 0.01). The current results indicate that quantitative67Ga‐SPECT/CT is useful for distinguishing patients with LLOM likely to require osteotomy.